We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current EMMA market cap is 2.55M. The company's latest EPS is USD -0.0585 and P/E is -47.35.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 22.75M | 23.17M | 20.61M | 18.39M | 29.6M |
| Operating Income | -4.93M | -2.35M | -8.86M | -8.5M | 1.83M |
| Net Income | -54.84M | 1.1M | -15.95M | -10.63M | -3.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 59.46M | 59.28M | 56.73M | 48.23M | 35.18M |
| Total Liabilities | 70.51M | 64.69M | 78.18M | 82.32M | 82.94M |
| Total Equity | -11.05M | -5.42M | -21.45M | -34.09M | -47.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.52M | -2.45M | -1.25M | -5.07M | -1.5M |
| Investing | -1.48M | 5.47M | -6.38M | -2.39M | -432k |
| Financing | 3.88M | -2.31M | 7.41M | 7.23M | 2.48M |
| Market Cap | 2.55M |
| Price to Earnings Ratio | -47.35 |
| Price to Sales Ratio | 5.98 |
| Price to Cash Ratio | 69.42 |
| Price to Book Ratio | -3.7 |
| Dividend Yield | - |
| Shares Outstanding | 63.87M |
| Average Volume (1 week) | 10.63k |
| Average Volume (1 Month) | 34.95k |
| 52 Week Change | -72.48% |
| 52 Week High | 0.17 |
| 52 Week Low | 0.0001 |
| Spread (Intraday) | 0.03 (73.43%) |
| Company Name | Emmaus Life Sciences Inc (PK) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.emmausmedical.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
